Related Experiment Video

Updated: Aug 13, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

[Osteopenia of prematurity]

István Kocsis1, Eva Kis, András Szabó

  • 1MTA Semmelweis Egyetem, Gyermekgyógyászati es Nefrológiai Kutatócsoport, I. Gyermekgyógyászati Klinika, Budapest. kopist@gyer1.sote.hu

Orvosi Hetilap
|January 10, 2006
PubMed

Insights

Osteopenia of prematurity is a growing concern in premature infants, affecting up to 30% of those born before 28 weeks. This review covers prevention and treatment to ensure optimal bone health and prevent adult osteoporosis.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Bone Metabolism

Context:

  • Increased survival rates of premature infants have led to a rise in chronic conditions like osteopenia of prematurity.
  • Osteopenia of prematurity is diagnosed by reduced bone mineral density in preterm infants without signs of rickets.
  • Incidence is as high as 30% in infants born before 28 weeks of gestation.

Purpose:

  • To review current information on the prevention and treatment of osteopenia of prematurity.
  • To summarize strategies for avoiding fractures and bone deformities in preterm infants.
  • To emphasize achieving genetically determined peak bone mass for long-term skeletal health.

Summary:

  • Osteopenia of prematurity is characterized by low bone mineral density in preterm infants.
  • Diagnosis relies on bone density measurements, excluding other metabolic bone diseases.
  • Effective prevention and treatment are crucial for achieving optimal bone mass.

Impact:

  • Adequate bone mineralization in infancy is vital for preventing osteoporosis in adulthood.
  • Addressing osteopenia of prematurity is a significant public health concern.
  • Early intervention ensures better long-term skeletal health outcomes for premature infants.

More Related Videos

Cantilever Bending of Murine Femoral Necks06:44

Cantilever Bending of Murine Femoral Necks

Published on: January 5, 2022

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...